ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastric Cancer Diagnostics Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-23A13695
Home | Market Reports | Health| Health Conditions| Cancer
Global Gastric Cancer Diagnostics Market Research Report 2023
BUY CHAPTERS

Global Gastric Cancer Diagnostics Market Research Report 2025

Code: QYRE-Auto-23A13695
Report
April 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teco Diagnostics
Vela Diagnostics
Thermo Fisher Scientific
F.Hoffmann-La Roche
General Electric
Agilent Technologies
Biohit Oyj
Biocept
Foundation Medicine
DiaSorin
Paragon Genomics
bioMérieux
Qiagen NV
Abbott, AdvaCare Pharma
Fujirebio (An H.U. Group company)
Endofotonics
ACON Laboratories
Myriad Genetics

Gastric Cancer Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gastric Cancer Diagnostics Market

Gastric Cancer Diagnostics Market

The global market for Gastric Cancer Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastric Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Cancer Diagnostics.
The Gastric Cancer Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastric Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastric Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gastric Cancer Diagnostics Market Report

Report Metric Details
Report Name Gastric Cancer Diagnostics Market
CAGR 5%
Segment by Type
Segment by Application
  • Male
  • Female
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Myriad Genetics, ACON Laboratories, Teco Diagnostics, Vela Diagnostics, Abbott, AdvaCare Pharma, Fujirebio (An H.U. Group company), Thermo Fisher Scientific, F. Hoffmann-La Roche, General Electric, Agilent Technologies, Endofotonics, Biohit Oyj, BIOCEPT, FOUNDATION MEDICINE, DiaSorin S.p.A, Paragon Genomics, BIOMÉRIEUX, QIAGEN
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gastric Cancer Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gastric Cancer Diagnostics Market report?

Ans: The main players in the Gastric Cancer Diagnostics Market are Myriad Genetics, ACON Laboratories, Teco Diagnostics, Vela Diagnostics, Abbott, AdvaCare Pharma, Fujirebio (An H.U. Group company), Thermo Fisher Scientific, F. Hoffmann-La Roche, General Electric, Agilent Technologies, Endofotonics, Biohit Oyj, BIOCEPT, FOUNDATION MEDICINE, DiaSorin S.p.A, Paragon Genomics, BIOMÉRIEUX, QIAGEN

What are the Application segmentation covered in the Gastric Cancer Diagnostics Market report?

Ans: The Applications covered in the Gastric Cancer Diagnostics Market report are Male, Female

What are the Type segmentation covered in the Gastric Cancer Diagnostics Market report?

Ans: The Types covered in the Gastric Cancer Diagnostics Market report are Instrument, Reagent Consumables, Service

Recommended Reports

Cancer Diagnostics

Gastrointestinal Diseases

Cancer Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastric Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instrument
1.2.3 Reagent Consumables
1.2.4 Service
1.3 Market by Application
1.3.1 Global Gastric Cancer Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Male
1.3.3 Female
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastric Cancer Diagnostics Market Perspective (2020-2031)
2.2 Global Gastric Cancer Diagnostics Growth Trends by Region
2.2.1 Global Gastric Cancer Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gastric Cancer Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Gastric Cancer Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Gastric Cancer Diagnostics Market Dynamics
2.3.1 Gastric Cancer Diagnostics Industry Trends
2.3.2 Gastric Cancer Diagnostics Market Drivers
2.3.3 Gastric Cancer Diagnostics Market Challenges
2.3.4 Gastric Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastric Cancer Diagnostics Players by Revenue
3.1.1 Global Top Gastric Cancer Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Gastric Cancer Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Gastric Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gastric Cancer Diagnostics Revenue
3.4 Global Gastric Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Gastric Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastric Cancer Diagnostics Revenue in 2024
3.5 Global Key Players of Gastric Cancer Diagnostics Head office and Area Served
3.6 Global Key Players of Gastric Cancer Diagnostics, Product and Application
3.7 Global Key Players of Gastric Cancer Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastric Cancer Diagnostics Breakdown Data by Type
4.1 Global Gastric Cancer Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Gastric Cancer Diagnostics Forecasted Market Size by Type (2026-2031)
5 Gastric Cancer Diagnostics Breakdown Data by Application
5.1 Global Gastric Cancer Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Gastric Cancer Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gastric Cancer Diagnostics Market Size (2020-2031)
6.2 North America Gastric Cancer Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gastric Cancer Diagnostics Market Size by Country (2020-2025)
6.4 North America Gastric Cancer Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastric Cancer Diagnostics Market Size (2020-2031)
7.2 Europe Gastric Cancer Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gastric Cancer Diagnostics Market Size by Country (2020-2025)
7.4 Europe Gastric Cancer Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastric Cancer Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Gastric Cancer Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gastric Cancer Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Gastric Cancer Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastric Cancer Diagnostics Market Size (2020-2031)
9.2 Latin America Gastric Cancer Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gastric Cancer Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Gastric Cancer Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastric Cancer Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Gastric Cancer Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gastric Cancer Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Gastric Cancer Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Details
11.1.2 Myriad Genetics Business Overview
11.1.3 Myriad Genetics Gastric Cancer Diagnostics Introduction
11.1.4 Myriad Genetics Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.1.5 Myriad Genetics Recent Development
11.2 ACON Laboratories
11.2.1 ACON Laboratories Company Details
11.2.2 ACON Laboratories Business Overview
11.2.3 ACON Laboratories Gastric Cancer Diagnostics Introduction
11.2.4 ACON Laboratories Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.2.5 ACON Laboratories Recent Development
11.3 Teco Diagnostics
11.3.1 Teco Diagnostics Company Details
11.3.2 Teco Diagnostics Business Overview
11.3.3 Teco Diagnostics Gastric Cancer Diagnostics Introduction
11.3.4 Teco Diagnostics Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.3.5 Teco Diagnostics Recent Development
11.4 Vela Diagnostics
11.4.1 Vela Diagnostics Company Details
11.4.2 Vela Diagnostics Business Overview
11.4.3 Vela Diagnostics Gastric Cancer Diagnostics Introduction
11.4.4 Vela Diagnostics Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.4.5 Vela Diagnostics Recent Development
11.5 Abbott, AdvaCare Pharma
11.5.1 Abbott, AdvaCare Pharma Company Details
11.5.2 Abbott, AdvaCare Pharma Business Overview
11.5.3 Abbott, AdvaCare Pharma Gastric Cancer Diagnostics Introduction
11.5.4 Abbott, AdvaCare Pharma Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.5.5 Abbott, AdvaCare Pharma Recent Development
11.6 Fujirebio (An H.U. Group company)
11.6.1 Fujirebio (An H.U. Group company) Company Details
11.6.2 Fujirebio (An H.U. Group company) Business Overview
11.6.3 Fujirebio (An H.U. Group company) Gastric Cancer Diagnostics Introduction
11.6.4 Fujirebio (An H.U. Group company) Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.6.5 Fujirebio (An H.U. Group company) Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Gastric Cancer Diagnostics Introduction
11.7.4 Thermo Fisher Scientific Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Details
11.8.2 F. Hoffmann-La Roche Business Overview
11.8.3 F. Hoffmann-La Roche Gastric Cancer Diagnostics Introduction
11.8.4 F. Hoffmann-La Roche Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.8.5 F. Hoffmann-La Roche Recent Development
11.9 General Electric
11.9.1 General Electric Company Details
11.9.2 General Electric Business Overview
11.9.3 General Electric Gastric Cancer Diagnostics Introduction
11.9.4 General Electric Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.9.5 General Electric Recent Development
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Details
11.10.2 Agilent Technologies Business Overview
11.10.3 Agilent Technologies Gastric Cancer Diagnostics Introduction
11.10.4 Agilent Technologies Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.10.5 Agilent Technologies Recent Development
11.11 Endofotonics
11.11.1 Endofotonics Company Details
11.11.2 Endofotonics Business Overview
11.11.3 Endofotonics Gastric Cancer Diagnostics Introduction
11.11.4 Endofotonics Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.11.5 Endofotonics Recent Development
11.12 Biohit Oyj
11.12.1 Biohit Oyj Company Details
11.12.2 Biohit Oyj Business Overview
11.12.3 Biohit Oyj Gastric Cancer Diagnostics Introduction
11.12.4 Biohit Oyj Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.12.5 Biohit Oyj Recent Development
11.13 BIOCEPT
11.13.1 BIOCEPT Company Details
11.13.2 BIOCEPT Business Overview
11.13.3 BIOCEPT Gastric Cancer Diagnostics Introduction
11.13.4 BIOCEPT Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.13.5 BIOCEPT Recent Development
11.14 FOUNDATION MEDICINE
11.14.1 FOUNDATION MEDICINE Company Details
11.14.2 FOUNDATION MEDICINE Business Overview
11.14.3 FOUNDATION MEDICINE Gastric Cancer Diagnostics Introduction
11.14.4 FOUNDATION MEDICINE Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.14.5 FOUNDATION MEDICINE Recent Development
11.15 DiaSorin S.p.A
11.15.1 DiaSorin S.p.A Company Details
11.15.2 DiaSorin S.p.A Business Overview
11.15.3 DiaSorin S.p.A Gastric Cancer Diagnostics Introduction
11.15.4 DiaSorin S.p.A Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.15.5 DiaSorin S.p.A Recent Development
11.16 Paragon Genomics
11.16.1 Paragon Genomics Company Details
11.16.2 Paragon Genomics Business Overview
11.16.3 Paragon Genomics Gastric Cancer Diagnostics Introduction
11.16.4 Paragon Genomics Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.16.5 Paragon Genomics Recent Development
11.17 BIOMÉRIEUX
11.17.1 BIOMÉRIEUX Company Details
11.17.2 BIOMÉRIEUX Business Overview
11.17.3 BIOMÉRIEUX Gastric Cancer Diagnostics Introduction
11.17.4 BIOMÉRIEUX Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.17.5 BIOMÉRIEUX Recent Development
11.18 QIAGEN
11.18.1 QIAGEN Company Details
11.18.2 QIAGEN Business Overview
11.18.3 QIAGEN Gastric Cancer Diagnostics Introduction
11.18.4 QIAGEN Revenue in Gastric Cancer Diagnostics Business (2020-2025)
11.18.5 QIAGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Teco Diagnostics
Vela Diagnostics
Thermo Fisher Scientific
F.Hoffmann-La Roche
General Electric
Agilent Technologies
Biohit Oyj
Biocept
Foundation Medicine
DiaSorin
Paragon Genomics
bioMérieux
Qiagen NV
Abbott, AdvaCare Pharma
Fujirebio (An H.U. Group company)
Endofotonics
ACON Laboratories
Myriad Genetics
List of Tables
 Table 1. Global Gastric Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Instrument
 Table 3. Key Players of Reagent Consumables
 Table 4. Key Players of Service
 Table 5. Global Gastric Cancer Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Gastric Cancer Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Gastric Cancer Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Gastric Cancer Diagnostics Market Share by Region (2020-2025)
 Table 9. Global Gastric Cancer Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Gastric Cancer Diagnostics Market Share by Region (2026-2031)
 Table 11. Gastric Cancer Diagnostics Market Trends
 Table 12. Gastric Cancer Diagnostics Market Drivers
 Table 13. Gastric Cancer Diagnostics Market Challenges
 Table 14. Gastric Cancer Diagnostics Market Restraints
 Table 15. Global Gastric Cancer Diagnostics Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Gastric Cancer Diagnostics Market Share by Players (2020-2025)
 Table 17. Global Top Gastric Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Cancer Diagnostics as of 2024)
 Table 18. Ranking of Global Top Gastric Cancer Diagnostics Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Gastric Cancer Diagnostics Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Gastric Cancer Diagnostics, Headquarters and Area Served
 Table 21. Global Key Players of Gastric Cancer Diagnostics, Product and Application
 Table 22. Global Key Players of Gastric Cancer Diagnostics, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Gastric Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Gastric Cancer Diagnostics Revenue Market Share by Type (2020-2025)
 Table 26. Global Gastric Cancer Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Gastric Cancer Diagnostics Revenue Market Share by Type (2026-2031)
 Table 28. Global Gastric Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Gastric Cancer Diagnostics Revenue Market Share by Application (2020-2025)
 Table 30. Global Gastric Cancer Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Gastric Cancer Diagnostics Revenue Market Share by Application (2026-2031)
 Table 32. North America Gastric Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Gastric Cancer Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Gastric Cancer Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Gastric Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Gastric Cancer Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Gastric Cancer Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Gastric Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Gastric Cancer Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Gastric Cancer Diagnostics Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Gastric Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Gastric Cancer Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Gastric Cancer Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Gastric Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Gastric Cancer Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Gastric Cancer Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Myriad Genetics Company Details
 Table 48. Myriad Genetics Business Overview
 Table 49. Myriad Genetics Gastric Cancer Diagnostics Product
 Table 50. Myriad Genetics Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 51. Myriad Genetics Recent Development
 Table 52. ACON Laboratories Company Details
 Table 53. ACON Laboratories Business Overview
 Table 54. ACON Laboratories Gastric Cancer Diagnostics Product
 Table 55. ACON Laboratories Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 56. ACON Laboratories Recent Development
 Table 57. Teco Diagnostics Company Details
 Table 58. Teco Diagnostics Business Overview
 Table 59. Teco Diagnostics Gastric Cancer Diagnostics Product
 Table 60. Teco Diagnostics Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 61. Teco Diagnostics Recent Development
 Table 62. Vela Diagnostics Company Details
 Table 63. Vela Diagnostics Business Overview
 Table 64. Vela Diagnostics Gastric Cancer Diagnostics Product
 Table 65. Vela Diagnostics Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 66. Vela Diagnostics Recent Development
 Table 67. Abbott, AdvaCare Pharma Company Details
 Table 68. Abbott, AdvaCare Pharma Business Overview
 Table 69. Abbott, AdvaCare Pharma Gastric Cancer Diagnostics Product
 Table 70. Abbott, AdvaCare Pharma Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 71. Abbott, AdvaCare Pharma Recent Development
 Table 72. Fujirebio (An H.U. Group company) Company Details
 Table 73. Fujirebio (An H.U. Group company) Business Overview
 Table 74. Fujirebio (An H.U. Group company) Gastric Cancer Diagnostics Product
 Table 75. Fujirebio (An H.U. Group company) Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 76. Fujirebio (An H.U. Group company) Recent Development
 Table 77. Thermo Fisher Scientific Company Details
 Table 78. Thermo Fisher Scientific Business Overview
 Table 79. Thermo Fisher Scientific Gastric Cancer Diagnostics Product
 Table 80. Thermo Fisher Scientific Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 81. Thermo Fisher Scientific Recent Development
 Table 82. F. Hoffmann-La Roche Company Details
 Table 83. F. Hoffmann-La Roche Business Overview
 Table 84. F. Hoffmann-La Roche Gastric Cancer Diagnostics Product
 Table 85. F. Hoffmann-La Roche Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 86. F. Hoffmann-La Roche Recent Development
 Table 87. General Electric Company Details
 Table 88. General Electric Business Overview
 Table 89. General Electric Gastric Cancer Diagnostics Product
 Table 90. General Electric Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 91. General Electric Recent Development
 Table 92. Agilent Technologies Company Details
 Table 93. Agilent Technologies Business Overview
 Table 94. Agilent Technologies Gastric Cancer Diagnostics Product
 Table 95. Agilent Technologies Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 96. Agilent Technologies Recent Development
 Table 97. Endofotonics Company Details
 Table 98. Endofotonics Business Overview
 Table 99. Endofotonics Gastric Cancer Diagnostics Product
 Table 100. Endofotonics Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 101. Endofotonics Recent Development
 Table 102. Biohit Oyj Company Details
 Table 103. Biohit Oyj Business Overview
 Table 104. Biohit Oyj Gastric Cancer Diagnostics Product
 Table 105. Biohit Oyj Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 106. Biohit Oyj Recent Development
 Table 107. BIOCEPT Company Details
 Table 108. BIOCEPT Business Overview
 Table 109. BIOCEPT Gastric Cancer Diagnostics Product
 Table 110. BIOCEPT Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 111. BIOCEPT Recent Development
 Table 112. FOUNDATION MEDICINE Company Details
 Table 113. FOUNDATION MEDICINE Business Overview
 Table 114. FOUNDATION MEDICINE Gastric Cancer Diagnostics Product
 Table 115. FOUNDATION MEDICINE Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 116. FOUNDATION MEDICINE Recent Development
 Table 117. DiaSorin S.p.A Company Details
 Table 118. DiaSorin S.p.A Business Overview
 Table 119. DiaSorin S.p.A Gastric Cancer Diagnostics Product
 Table 120. DiaSorin S.p.A Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 121. DiaSorin S.p.A Recent Development
 Table 122. Paragon Genomics Company Details
 Table 123. Paragon Genomics Business Overview
 Table 124. Paragon Genomics Gastric Cancer Diagnostics Product
 Table 125. Paragon Genomics Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 126. Paragon Genomics Recent Development
 Table 127. BIOMÉRIEUX Company Details
 Table 128. BIOMÉRIEUX Business Overview
 Table 129. BIOMÉRIEUX Gastric Cancer Diagnostics Product
 Table 130. BIOMÉRIEUX Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 131. BIOMÉRIEUX Recent Development
 Table 132. QIAGEN Company Details
 Table 133. QIAGEN Business Overview
 Table 134. QIAGEN Gastric Cancer Diagnostics Product
 Table 135. QIAGEN Revenue in Gastric Cancer Diagnostics Business (2020-2025) & (US$ Million)
 Table 136. QIAGEN Recent Development
 Table 137. Research Programs/Design for This Report
 Table 138. Key Data Information from Secondary Sources
 Table 139. Key Data Information from Primary Sources
 Table 140. Authors List of This Report


List of Figures
 Figure 1. Gastric Cancer Diagnostics Picture
 Figure 2. Global Gastric Cancer Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gastric Cancer Diagnostics Market Share by Type: 2024 VS 2031
 Figure 4. Instrument Features
 Figure 5. Reagent Consumables Features
 Figure 6. Service Features
 Figure 7. Global Gastric Cancer Diagnostics Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Gastric Cancer Diagnostics Market Share by Application: 2024 VS 2031
 Figure 9. Male Case Studies
 Figure 10. Female Case Studies
 Figure 11. Gastric Cancer Diagnostics Report Years Considered
 Figure 12. Global Gastric Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Gastric Cancer Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Gastric Cancer Diagnostics Market Share by Region: 2024 VS 2031
 Figure 15. Global Gastric Cancer Diagnostics Market Share by Players in 2024
 Figure 16. Global Top Gastric Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Cancer Diagnostics as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Gastric Cancer Diagnostics Revenue in 2024
 Figure 18. North America Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Gastric Cancer Diagnostics Market Share by Country (2020-2031)
 Figure 20. United States Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Gastric Cancer Diagnostics Market Share by Country (2020-2031)
 Figure 24. Germany Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Gastric Cancer Diagnostics Market Share by Region (2020-2031)
 Figure 32. China Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Gastric Cancer Diagnostics Market Share by Country (2020-2031)
 Figure 40. Mexico Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Gastric Cancer Diagnostics Market Share by Country (2020-2031)
 Figure 44. Turkey Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Gastric Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Myriad Genetics Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 48. ACON Laboratories Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 49. Teco Diagnostics Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 50. Vela Diagnostics Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 51. Abbott, AdvaCare Pharma Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 52. Fujirebio (An H.U. Group company) Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 54. F. Hoffmann-La Roche Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 55. General Electric Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 56. Agilent Technologies Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 57. Endofotonics Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 58. Biohit Oyj Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 59. BIOCEPT Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 60. FOUNDATION MEDICINE Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 61. DiaSorin S.p.A Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 62. Paragon Genomics Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 63. BIOMÉRIEUX Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 64. QIAGEN Revenue Growth Rate in Gastric Cancer Diagnostics Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Stomach Cancer Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Diagnostics Service Market Research Report 2025
Global Gynecological Cancer Diagnostics Market Research Report 2025
Liver Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Diagnostic Kit Market Research Report 2024
Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non invasive Helicobacter Pylori Diagnostic Testing Market Research Report 2024
Precision Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Skin Cancer Diagnostics Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Brain Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Next Generation Gynecological Cancer Diagnostics Market Research Report 2024
Cancer Generics Market
Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non invasive Helicobacter Pylori Diagnostic Market Research Report 2025
Global Cancer Tissue Diagnostics Market Research Report 2024
Stomach Peptic Ulcer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Immuno oncology Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Next Generation Breast Cancer Diagnostic and Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Based Molecular Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions